First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan Deeksha Bhandari15 May 2025 12:42 PM ISTA recent expert group consensus has endorsed the use of vonoprazan for managing refractory gastroesophageal reflux disease (rGERD) in Indian...
Vonoprazan for PPI-Refractory Functional Dyspepsia among Asian Patients, Study Highlights Deeksha Bhandari27 Jan 2025 11:45 AM ISTA recent study published in the December issue of the Journal of Gastroenterology and Hepatology highlights Vonoprazan's significant effectiveness in...
Rabeprazole in GERD and Nocturnal Reflux Management - Dr G. Manoharan MDTV Bureau7 Jan 2025 12:37 PM ISTGastroesophageal reflux disease (GERD) is a common condition globally. The severity of GERD largely depends on the extent and duration of esophageal...
Multidisciplinary Indian Consensus for Rationalizing the Use of Acid Suppressants in Children and Adults: Key Takeaways from CONFOR CONSENSUS MD Brand Connect17 July 2024 9:45 AM ISTA Multidisciplinary Consensus for Rationalizing the Use of Acid Suppressants in Children and Adults: CONFOR CONSENSUS has been recently published in...
2024 CONFOR Consensus: Rationalizing Use of Acid Suppressants in Children and Adults Dr. Kamal Kant Kohli10 July 2024 12:57 PM ISTConcern about the inappropriate use of proton pump inhibitors (PPIs) has been rising, with studies showing a lack of ongoing indication for PPI...
Understanding Post Meal Reflux and Benefits of Sodium Alginate - Dr Shubham Vatsya MD Brand Connect8 July 2024 11:52 AM ISTPost meal reflux refers to the phenomenon where patients experience severe burning in the middle of the chest shortly after eating. This discomfort...
Hetero Healthcare Ltd Launches Hetran- A New Era in Acid Blocker Therapy MD Brand Connect5 July 2024 11:30 AM ISTUnderstanding the growing need for effective gastric acid related diseases treatment, Hetero Healthcare Ltd, one of India's leading generic...
Hetero Healthcare Ltd Introduces Hetran, Pioneering a New Generation of Acid Blockers MD Brand Connect27 Jun 2024 12:20 PM ISTHetero Healthcare Ltd, one of India's leading pharmaceutical companies, has launched Vonoprazan, a new-age acid blocker, under the brand name Hetran....
Focus On: Co-prescribing Probiotics and Prebiotics with PPIs in India - Five Commandments MDTV Bureau9 Jan 2024 10:45 AM ISTPublished in the latest December issue of JAPI, the survey included 1007 health care professionals (HCPs) from across India. Based on consensus...
Insights into Co-prescribing Probiotics and Prebiotics with PPIs in India MD Brand Connect23 Dec 2023 10:00 AM ISTCo-prescribing pre-and probiotics mitigates the potential side effects of long-term PPI use, survey on 1000 plus doctors concludes.Published in the...
Scope of Pre-probiotics as Add-On to PPIs in Different Clinical Indication: 1000+ Indian HCPs Opine Dr. Kamal Kant Kohli8 Dec 2023 12:00 PM ISTCo-prescription of probiotics with proton pump inhibitors (PPIs) decreases the potential side effects associated with long-term PPI use and improves...
Faecal Calprotectin may help distinguish IBD from IBS in primary care setting Aditi14 Nov 2023 7:00 AM ISTFecal calprotectin (FC) is a reliable marker of intestinal inflammation. It differentiates between inflammatory bowel disease (IBD) and irritable...
